Galectin-3 (Gal-3) serves as a pivotal molecule in the intricate landscape of oncology, with expression patterns spanning a multitude of malignancies, including gastrointestinal, cardiovascular, urinary, respiratory, breast, melanoma, and thyroid systems [34,35,36,37,38,39,40,41,42]. Here, LGALS3 is linked to melanoma.